In addition to the PI3K signaling pathway, SALL4/Wnt/β-catenin signaling has been shown to be associated with the clinicopathological features and prognosis of HCC patients (Wang et al. 2019b). The gene discussed is SALL4; the disease is hepatocellular carcinoma.